Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1990-01-12
1991-02-05
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Lymphokine
A61K 3912
Patent
active
049903675
ABSTRACT:
A vaccine composition for animals susceptible to infection by canine distemper virus. The vaccine comprises a small but immunologically effective amount of an inactivated canine distemper virus in combination with a non-toxic pharmaceutically acceptable immunologic adjuvant. A preferred method of inactivation of canine distemper virus by either exposure of the virus to an inactivating effective amount of binary ethyleneimine or alternatively exposure of the virus to long wavelength ultraviolet light in the presence of a furocoumarin.
REFERENCES:
patent: 1967476 (1934-07-01), Little
patent: 2136131 (1938-11-01), Green
patent: 2271818 (1942-02-01), Green
patent: 2271819 (1942-02-01), Green
patent: 2720484 (1955-10-01), Meadows et al.
patent: 2965544 (1960-12-01), Cabasso
patent: 3080291 (1963-03-01), Sinha et al.
patent: 3098011 (1963-07-01), Rockborn
patent: 3318775 (1967-05-01), Melvin et al.
patent: 3354038 (1967-11-01), Bass
patent: 3420934 (1969-01-01), Ackermann
patent: 3462526 (1969-08-01), de Ratuld et al.
patent: 3470294 (1969-09-01), Drager et al.
patent: 3594471 (1971-07-01), Hertzberger et al.
patent: 3636196 (1972-01-01), Bauer et al.
patent: 3836626 (1974-09-01), Lavender
patent: 3886270 (1975-05-01), Ackermann
patent: 4004974 (1977-01-01), Chumakov et al.
patent: 4036952 (1977-07-01), Bauer et al.
patent: 4071618 (1978-01-01), Konobe et al.
patent: 4112068 (1978-09-01), Cabasso
patent: 4347239 (1982-08-01), Bass et al.
patent: 4358438 (1982-11-01), Bijlenga
patent: 4545987 (1985-10-01), Giles et al.
patent: 4556556 (1985-12-01), Wiesehahn et al.
patent: 4567042 (1986-01-01), Acree et al.
patent: 4567043 (1986-01-01), Acree et al.
patent: 4693981 (1987-09-01), Wiesehahn et al.
Appel et al, Archives of Virology 82:73-82 (1984) Measles Virus and Inactivated Canine Distemper Virus Induce Incomplete Immunity to Canine Distemper.
Appel, M., 1984, Measles virus and inactivated canine distemper virus induc incomplete immunity to canine distemper, Arch. Virol. 82: 73-82.
Gillespie, J., 1965, A study of inactivated distemper virus in the dog, Cornell Vet. 55: 3-8.
Sheshberadaron, H., 1986, The antigenic relationship between measles, canine J. Gen. Virol. 67: 1381-1392.
Norrby, E., 1986, Protection against canine distemper virus in dogs after immunization with isolated fusion protein, J. Virol. 58: 536-541.
McCormick, A., 1983, Canine distemper in African cape hunting dogs (Lycoan pictus)--possibly vaccine induced, J. Zoo. Anim. Med. 14: 66-71.
Halbrooks, R., 1982, Response of gray foxes to modified live virus canine distemper vaccines, J. Am. Vet. Med. Assoc. 179: 1170-1174.
Hartley, W., 1974, A post-vaccinal inclusion body encephalitis in dogs, Vet. Pathol. 11: 301-312.
McAnulty, J., 1985, Thrombocytopenia associated with vaccination of a dog with a modified live paramyxovirus vaccine. J. Am. Vet. Med. Assoc. 186: 1217-1219.
McLaughlin, B., 1985, Canine distemper viral inclusions in blood cells of four vaccinated dogs. Canadian Vet. J. 26:368-372.
Krakowka, S., 1982, Canine parvovirus infection potentiates canine distemper J. Am. Vet. Med. Assoc. 180: 137-139.
Wilson, N., 1981, Distemper vaccine breakdowns. Vet. Rec. 108: 171.
Appel, M., 1978, Reversion to virulence of attenuated canine distemper virus in vivo and in vitro. J. Gen. Virol. 41: 385-393.
Bass Edmund P.
Kelsey William H.
McFarland Michael D.
Diamond Scientific Company
Gil Joseph C.
Griffin Ronald W.
Whalen Lyndanne M.
LandOfFree
Canine distemper virus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Canine distemper virus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine distemper virus vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-9673